Discovery of the first macrolide antibiotic binding protein in Mycobacterium tuberculosis: a new antibiotic resistance drug target.

Author: Qingqing ZHANG ¹ ; Huijuan LIU ¹ ; Xiang LIU ² ; Dunquan JIANG ¹ ; Bingjie ZHANG ³ ; Hongliang TIAN ⁴ ; Cheng YANG ² ; Luke W GUDDAT ⁵ ; Haitao YANG ⁴ ; Kaixia MI ³ ; Zihe RAO ⁶
Author Information

1. College of Life Sciences, Nankai University, Tianjin, 300071, China.
2. College of Pharmacy, Nankai University, Tianjin, 300071, China.
3. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
4. School of Life Sciences, Tianjin University, Tianjin, 300072, China.
5. School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, 4072, Australia.
6. College of Life Sciences, Nankai University, Tianjin, 300071, China. raozh@nankai.edu.cn.
Publication Type:Letter
MeSH: Anti-Bacterial Agents; chemistry; pharmacology; Drug Resistance, Bacterial; drug effects; Humans; Mycobacterium tuberculosis; chemistry; drug effects; Tuberculosis, Multidrug-Resistant; drug therapy; microbiology
From: Protein & Cell 2018;9(11):971-975
CountryChina
Language:English